Temple Researchers and Biotech Spinoff Chase an HIV Cure By Mark TerryMay 4, 2023 Three people have been known to have been “cured” of HIV, meaning that the virus was [….]
Temple Researchers and Biotech Spinoff Chase an HIV Cure
Uvax Bio Preps to Take HIV Vaccine into the Clinic
Uvax Bio Preps to Take HIV Vaccine into the Clinic By Mark TerryMay 2, 2023 Uvax Bio, headquartered in Newark, Del., recently published preclinical results in Nature Communications showing the [….]
“DNA Valley” Continues to Flourish in Maryland, the Birthplace of the Human Genome Project
Jeff Galvin, the CEO of American Gene TechnologiesⓇ, one of the leading biotech companies in Maryland, has championed the state as “DNA Valley.” And Galvin should know: he came to Maryland after a successful career in Silicon Valley and sees parallels between the early days of an emerging Silicon Valley and what’s going on today in DNA Valley, which currently stretches from Montgomery County and Frederick, Maryland all the way up to Baltimore.
The Evolving Hunt for an HIV Cure, and How Gene Therapy is Paving the Way
Today, a host of life sciences companies are utilizing gene therapy as a tool to find a cure for HIV. When discussing an HIV cure, there are two different possible targets: a “functional cure” where HIV is not eradicated but rather totally controlled without further ART treatment and a “sterilizing cure” that eliminates HIV completely from the body.
American Gene Technologies says clinical trial shows increases in immunity against HIV
ROCKVILLE, Md. (7News) — There’s more good news in the fight to cure HIV.
American Gene Technologies says its clinical trial has resulted in more patients with substantial increases in virus-specific T-cells with immunity against HIV.
Progress in HIV cure: AGT hopes to have a ‘functionally cured patient by next summer’
“Now the question will be the very final step when we withdraw antiretroviral therapy, will it behave as we expect which is to take over viral suppression and these patients will not need to go back on their antiretroviral therapy again,” said CEO Jeff Galvin.
He says that process would start by the end of March at the earliest and he hopes to find out how successful it is by June.
Mission, Purpose, and Reducing Human Suffering Propel American Gene Technologies Forward
Rockville, Maryland’s American Gene Technologies (AGT) is on a mission to cure HIV. And they just achieved another important milestone in that potentially groundbreaking journey.
In early November 2021, the company announced that the third patient in its first-in-human study for AGT103-T, a cell therapy for HIV, had been dosed with no serious adverse events. This latest milestone achievement moves the company and its team another step closer to curing HIV and making history.
With a Chance to Cure HIV, American Gene Technologies Offers Employees a Front Seat to History
There is a growing movement of professionals seeking jobs with a purpose. The mission-driven culture of a company is a powerful attraction for those value-driven prospective applicants. Curing HIV is one of the bolder missions to be found in the I-270 technology corridor. With its bold mission to develop a cure for HIV, American Gene Technologies Business Development head Norman Rogers said that it’s an “attractive position for people who want a front seat to history.”
Dr. Anthony Fauci & AGT’s Jeff Galvin Join ‘I AM BIO’ to Discuss Future of HIV Treatments
EPISODE SUMMARY
For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company American Gene Technologies, Jeff Galvin, about the past, present, and future of HIV treatments and medications. Is there a cure on the horizon?
Guests:
Jeffrey Galvin, American Gene Technologies
Anthony Fauci, National Institute of Allergy and Infectious Diseases
EPISODE NOTES
For more than a year now, COVID has been society’s focus—and rightly so. But today we turn our attention to another virus—HIV. After 40 years, there is still no cure or a vaccine for the disease. In this episode, we hear from Dr. Anthony Fauci and CEO of innovative company American Gene Technologies, Jeff Galvin, about the past, present, and future of HIV treatments and medications. Is there a cure on the horizon?
Investors Eye Gene Therapy Companies and Rapidly Expanding Market
Investors Eye Gene Therapy Companies and Rapidly Expanding Market – Five Publicly Traded Gene Therapy Companies
AGT’s HIV Cure Cell Therapy Clears First Safety Hurdle with DSMB Nod
American Gene Technologies’ goal to develop a cure for HIV moved one step closer to reality. After infusing the first patient with its cell therapy candidate AGT103-T, the company announced the Data and Safety Monitoring Board unanimously supported the continuation of the clinical study without modification.